Extension Safety and Immunogenicity Study of GPNV-001

Clinical trial NCT05982314 · COMPLETED

Trial details

NCT number: NCT05982314
Sponsor: GPN Vaccines
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2023-07-17
Primary completion: 2024-08-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.